2-(PIPERIDIN-4-YLMETHYL)-4-(TRIFLUOROMETHYL)PYRIMIDINE HCL, 95.0%, 250mg

Ethanone, 1-[1-[2-(methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]-, 5mg

2-(4-Chloro-phenyl)-5-thiocyanato-[1,3,4]oxadiazole, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid, 95.0%, 10g

4-chloro-5,6-dimethyl-2-pyrrolidin-1-ylpyrimidine, 95.0%, 1g

3,4-Dimethoxyphenethyl alcohol, 98.0%, 5g

3-(4-METHOXYBENZYL)PIPERIDINE, 97.0%, 100mg

2,6-Dichloropyridine-3-boronic acid, 97.0%, 10g

Ethylene glycol, min. 98%, tech., 25 l, plastic packaging.

Ethyl 4,6-Dihydroxy-5-nitronicotinate, 97.0%, 25g

Gal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-beta-pNP5mg

(1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl (2-cyanoethyl) diisopropylphosphoramidite, 98%, 5g

Methyl 2,3-o-isopropylidene-beta-D-ribofuranoside, 95.0%, 100g